No Data
No Data
Beyond Air Files To Sell 81.7M Shares Of Common Stock For Holders
Beyond Cancer to Present Preclinical Data of Ultra-High Concentration Nitric Oxide (UNO) Low Volume Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Express News | Avenue Capital Management II, L.p. Reports 14.7% Passive Stake in Beyond Air Inc as of September 26 - SEC Filing
Express News | Beyond Air: Term Sheet Provides for Principal Amount of $11.5 Mln
Express News | Beyond Air: Entered Into Binding Term Sheet for Secured Loan With Some Lenders Including CEO Steven Lisi, Director Robert Carey
Beyond Air Shares Are Trading Higher After the Company Announced a Partnership With Healthcare Links to Expand Access to Beyond Air's LungFit PH System.